The Midazolam Injection, cataloged under National Stock Number 6505-01-695-1375, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Civica Inc. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-695-1375 |
| Primary Part Number | NDC72572-0432-10 |
| Item Name | Midazolam Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Civica Inc |
| Status | ACTIVE |
| Controlled Substance Classification | SCHEDULE IV |
| Administration | INTRAMUSCULAR AND INTRAVENOUS |
| Primary Container Content Quantity | 5.0 MILLIGRAMS |
| Secondary Container Type | PACKAGE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL, SINGLE DOSE |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC72572-0432-10 PRIMARY | Civica Inc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM217123 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1596335 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-695-1375 is a Midazolam Injection, manufactured by Civica Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-695-1375 has 1 manufacturer part number on file: NDC72572-0432-10 (Civica Inc).
Key specifications for NDC72572-0432-10: Controlled Substance Classification: SCHEDULE IV; Administration: INTRAMUSCULAR AND INTRAVENOUS; Primary Container Content Quantity: 5.0 MILLIGRAMS; Secondary Container Type: PACKAGE. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.